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Aim: Aim of the study is to evaluate breast masses using mammography (MG) and ultrasonography (USG) inde-
pendently and in combination.
Materials and methods: Our study group consisted of 62 female patients, with breast symptoms such as palpable 
lumps, pain in the breast and nipple discharge who were examined prospectively over a period of 6 months.
All 62 patients were examined by both MG and USG independently. Fine needle aspiration cytology (FNAC) or 
core cut biopsy was done according to the ﬁ  ndings of MG and USG and then the results were correlated with each 
modality ﬁ  nding. 
Results: According to this study MG showed an eﬃ   ciency of 81.8 % compared to 95.5 % for USG in detecting 
ﬁ  brocystic mastitis. However their combined approach resulted in 100 %. In the case of ﬁ  broadenomas, MG showed 
75 % eﬃ   ciency and USG only 35 % and the combination resulting in 93.7 %. For carcinomas, MG had an eﬃ   ciency 
of 77.8 % and USG 55.6 %, but the combination had an eﬃ   ciency of 98.1 %. Overall, the histopathological results 
when correlated with each modality ﬁ  nding showed that MG had an eﬃ   ciency of only 77.4 % and USG only 69.8 % 
when used alone in detecting these lesions of the breast compared to an eﬃ   ciency of 98.1 % obtained by their com-
bined approach. In our study, we showed that there was no signiﬁ  cant diﬀ  erence in sensitivity between MG and USG 
(p = 0.3768) but there was signiﬁ  cant diﬀ  erence in MG alone and MG-USG combination (p = 0.0015) and USG alone 
and USG-MG combination (p = 0.0001).
Conclusion: Our study conﬁ  rmed that combined MG and USG had higher sensitivity rate than the sensitivity rate 
observed for either single modality. The diagnostic accuracy for carcinomas of the breast appear to improve when MG 
was combined with USG, even in cases which showed no evidence of microcalciﬁ  cation or other signs of abnormalities. 
Our study implies that, USG may be the only viable modality in pregnant and lactating women as it does not involve 
ionizing radiation and also in dense breast tissue, as density is a limiting factor for MG.
INTRODUCTION
Breasts are a secondary sexual characteristic in fe-
males. They are also the source of nutrition for the ne-
onate and thus of mankind. They are also present in a 
rudimentary form in males. This tender, sensitive and 
delicate complex structure is constantly under the inﬂ  u-
ence of hormones1, 2. 
The breast develops from mammary ridges. After me-
narche, the young virgin breast contains more dense con-
nective tissue. With progression in age the dense breast 
becomes mixed glandular pattern tissue, and with further 
progression in age, breast begins to involute into fatty 
tissue.
Any aberration in this process leads to the susceptibil-
ity to a spectrum of localised pathologies like, hyperplas-
tic and neoplastic changes. Of the various pathologies 
that aﬄ   ict the breast, cancers are most often encountered 
and are the most dreaded1, 2. Despite the gloomy progno-
sis, increased morbidity and reduced survival time, it can 
be controlled if detection and diagnosis are made in the 
earliest stages i.e., in the pre-invasive and clinically non-
palpable stage.
Detection of breast cancer in its earliest possible stage 
is the ultimate goal in imaging the breast, and the role 
of the radiologist is therefore vital. Radiology chieﬂ  y in-
cludes MG (mammography) and USG (ultrasonography) 
followed by biopsy. The incidence of breast cancer deaths 
can be reduced by 30 % by the routine screening of healthy 
women with MG3, 4. This is because breast changes like 
asymmetry, neodensity, distortion of ﬁ  broglandular archi-
tecture and microcalciﬁ  cations are picked up earlier than 
lesions that become clinically palpable, or are sometimes 
detected by self-examination3, 4.
USG plays a key role in diﬀ  erentiating cystic and solid 
masses. It is useful in the evaluation of palpable masses 
not visible in radiographically dense breasts, abscesses, 
masses that are not completely evaluable with MG and in 
young patients susceptible to radiation damage4,5.
Both MG and USG methods have been used in at-
tempts to reduce the negative to positive biopsy ratio. 
Breast cancer mortality has declined since the early 1990s 316  S. Prasad N, D. Houserková
primarily due to increase in breast cancer awareness, 
screening and detection of early cancer6. The false-nega-
tive rate of mammography in the detection of breast can-
cer has been consistently reported to be approximately 
10 %, as determined by studies such as the Breast Cancer 
Detection Demonstration Project6. These mammographi-
cally occult lesions are usually discovered by physical 
examination and often occur in women with mammo-
graphically dense breasts. Therefore, a negative mammo-
graphic result cannot exclude malignancy in women with 
a palpable mass; the lesion should be biopsied if clinically 
indicated. The sonographic evaluation of a palpable breast 
mass is based on three categories. First, if the lesion is a 
simple cyst, no further workup is required, although as-
piration can be performed if desired by the patient or 
physician. Second, if the palpable lesion is a solid mass 
or complex cyst, further intervention is often required, 
such as ﬁ  ne-needle aspiration or core cut biopsy. Third, 
if ﬁ  ndings from the sonography are negative (no discrete 
cystic or solid lesions are seen to correlate with the pal-
pable mass) and the ﬁ  ndings from the mammography are 
negative, then the treatment of the palpable abnormality is 
based on the results of the physical examination.
MATERIALS AND METHODS
A group of 62 female patients with breast symptoms, 
such as palpable lumps, pain in the breast and nipple 
discharge were examined prospectively over a period of 
6 months. Both MG and USG were used independently 
to examine these patients. 
Clinical examination:
In terms of age, 20 patients were less than 30 yrs, 
19 patients between 31 to 40 yrs and the rest were above 
40yrs as given in Table 1.
The patients were examined clinically and they showed 
either movable well-deﬁ  ned masses with a stony hard con-
sistency, or restricted mobility of ill-deﬁ  ned masses with 
stony hard consistency. Some patients showed diﬀ  use ill-
deﬁ  ned indurations with nipple discharge. 
All the patients were given adequate explanation about 
the procedures and consent was obtained. 
53 patients underwent FNAC (ﬁ  ne needle aspiration 
cytology) and core cut biopsy according to the ﬁ  ndings 
of USG and MG. Later HPE (histopathological examina-
tion) results obtained was correlated with each modal-
ity ﬁ  nding. With the USG examination, cystic and solid 
masses were also analyzed. Using MG, the patients were 
analyzed for the parenchymal pattern of the breast accord-
ing to TABAR’S classiﬁ  cation and the histopathological 
examination (HPE) correlation of the masses present in 
them.
Masses in the breast were also classiﬁ  ed according to 
the USG predominant pattern. These were cystic, solid 
and mixed patterns.
Equipment:
MG was performed in a stand type PHILIPS MAMMO-
DIAGNOST which is a radiographic stand to radiograph 
the subject in a standing or sitting position in combination 
with mammographic x-ray tube assembly with compres-
sion paddle.
The cassette used for MG was KodakMin 30 R with 
single sided screen with ultra sensitive ﬁ  lms with emulsion 
coated on a single side of size 8X10”. 
Each palpable lesion was evaluated with MG using the 
ﬁ  lm-screen technique. Mediolateral oblique and cranio-
caudal images were obtained and assessed carefully.
USG was performed on a PHILIPS ENVISOR, real 
time scanner with a hand held linear electronic array 
transducer. The transducer could be operated in the 
frequency range of 7.5 MHz and was provided with a 
built-in ﬂ  uid oﬀ  set. USG targeted to the palpable lesions 
were obtained for each patient by a professional breast 
imaging radiologist.
RESULTS
The HPE report revealed 9 patients with a carcinoma 
where, the MG detected 7 and USG alone detected only 5. 
There were 3 cases of cyst, which was clearly detected by 
USG, but the MG picked up only 2. Out of the 22 cases 
of ﬁ  brocystic mastitis, MG alone picked 18 whereas the 
USG missed only 1. Among 2 cases of infective pathology 
the MG missed 1, whereas the USG correctly spotted the 
2. Of 16 cases of ﬁ  broadenoma, the MG detected 12 and 
the USG detected 5. And ﬁ  nally 1 case of cystosarcoma 
phylloids where both the modalities were successful, in-
dependently. This is shown clearly in Table 2.
As mentioned above, of 22 cases of ﬁ  brocystic mas-
titis, the MG alone picked up 18 cases, the remaining 
4 were cases of sector mastitis which was misdiagnosed 
as diﬀ  use lumps, and carcinoma could not be excluded. 
USG could not correctly diagnose 1 case out of the 22, 
as the lesion appeared hypoechoic and showed no cysts 
or echogenic ﬁ  brous tissue. HPE in this case, revealed a 
glistening white lump, which was diagnosed as ﬁ  brosing 
mastopathy. By the combined USG and MG approach 
all 22 cases were correctly diagnosed. In this study USG 
provided a better description of the lesions in ﬁ  brocystic 
Table 1. Age distribution of the patients.
Age group No: of patients
Below 30 years 20 patients
31–40 Years 19 patients
41–50 Years 16 patients
51–60 Years 4 patients
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mastitis. A tiny cyst surrounded by echogenic ﬁ  brous tis-
sue was the typical appearance on USG. This could be 
easily distinguished from carcinoma, which appears hyp-
oechoic. Hence, sector mastitis mistaken for carcinoma 
on MG, could be easily diﬀ  erentiated on USG. 
Out of the 2 cases of infective pathologies, MG missed 
1 case, which was misdiagnosed as carcinoma. This is 
because on MG breast abscess appears as a poorly de-
ﬁ  ned mass or a mass with spiculated borders because of 
inadequate compression. USG alone could correctly pick 
2 cases. The ﬁ  rst case showed features of a simple cyst and 
was probably an infected cyst. The combined approach 
could do no better than USG alone. In our study, it was 
observed that most abscesses had no deﬁ  nite shape and 
had irregular contours with weak internal echoes in either 
homogeneous or scattered distribution. Most of the ab-
scesses also had moving echoes within them due to ﬂ  oat-
ing debris, which was an important diﬀ  erentiating feature. 
Some of them showed posterior acoustic enhancement, 
while others did not. However, none of them showed pos-
terior acoustic shadowing. It was therefore concluded that 
most of the abscesses that mimic carcinoma on MG could 
be correctly diagnosed by the combined approach. The 
above evidence shows that when the two modalities were 
combined, they yielded signiﬁ  cant improvement in results 
than they did independently. The appearance of a benign 
Fig. 1.  Ultrasonography of a benign cyst.
  The arrow points the cystic area in the breast.
Fig. 2.  Mammographic image of breast cancer
The arrow points the area of cancer.
Table 2. HPE ﬁ  ndings with comparative analysis.
HPE diagnosis entities No. Of Cases Mammography 
Alone USG Alone Combined
Fibrocystic mastitis 22 18(82%) 21(95%) 22 (100%)
Infection 2 1(50%) 2(100%) 2(100%)
Fibroadenoma 16 12(75%) 5(31%) 15 (93%)
Cyst 3 2(67%) 3(100%) 3(100%)
Carcinoma 9 7(77%) 5(55%) 9(100%)
Phylloids tumour 1 1(100%) 1(100%) 1(100%)
Total 53 41(77%) 37(70%) 52 (98%)
cyst under USG and image of breast cancer under MG are 
shown in ﬁ  gures 1&2 respectively. The analysis of solid 
and cystic masses by USG is given clearly in Table 3 and 
the mammographic parenchymal pattern of the breast 
according to Tabar’s classiﬁ  cation in Table 4.
According to MG, the lesions were also analyzed on 
the basis of their location (relation to their quadrant), 
number of asymmetrical lesions, well deﬁ  ned or merging 
with the adjacent normal breast tissue, according to the 
density of the lesion, margins, surrounding halo, and the 318  S. Prasad N, D. Houserková
Table 3. Ultrasonographic Findings.
S.N0 12345
HPE Fibrocystic Mastitis Fibro adenoma Cyst Infection Malignancy
No: of Cases 
Diagnosed 2 1 5325
Quadrants Upper outer
Upper outer 
Retro-areolar
Upper outer
 any
Upper outer
Upper outer, lower 
outer, any
Unilateral (or) 
Bilateral Bilateral Both Unilateral Unilateral Unilateral
Echogenicity of 
lesion Hypoechoic Hypoechoic Anechoic
Anechoic to 
hypoechoic
Mixed echogenicity
Margin Diﬀ  use Well deﬁ  ned Well deﬁ  ned Well deﬁ  ned Irregular
Ca + + – Coarse – –
7 cases 
Show micro-
calciﬁ  cation
Single (or) Multiple Single Single Single Single
Skin Inﬁ  ltration – – – Focal thickening
3 cases 
Skin thickening
With Internal echoes –
Homogenously 
ﬁ  lling up when gain 
is raised.
Central Area 
persistently 
Anechoic 
With internal echoes 
(moving)
–
Without Internal 
echoes +–
+ +
 (2 Cases)
––
Posterior 
Enhancement – 2 Cases
+ +
 (2 Cases)
+ + 3 Cases
Posterior Acoustic 
shadowing – 3 Cases – – 18 Cases
Table 4. Mammographic parenchymal pattern according to TABAR’S classiﬁ  cation.
Consistency of the breast under TABAR Normal  Benign Malignant Total
Mixed glandular pattern/TABAR I  2 4 5 11
Fatty Breast/TABAR II & III 1 12 1 14
Dense Breast/TABAR IV & V 18 18 1 37
Total 21 34 7 62
presence or absence of intra mammary and axillary le-
sions. The analysis is given in Table 5.
Various limitations of mammography were that, solid 
cystic masses could not be diﬀ  erentiated and intra cystic 
lesions could not be diagnosed. The young breast had 
dense ﬁ  broglandular parenchyma, which obscured masses 
under MG. Overlapping structures limited complete visu-
alisation of masses. The major advantages of MG were 
that, microcalciﬁ  cations could be seen well and multicen-
tric carcinomas could be diagnosed. The limitations of 
USG were that, isoechoeic masses were at times missed 
if they were especially small. Microcalciﬁ  cations if small 
were also not picked and lesions within large fatty breasts 
were diﬃ   cult to diagnose. However, the real advantage of 
USG was that solid and cystic masses could be diﬀ  erenti-
ated well and young breasts with dense ﬁ  bro-glandular 
parenchyma could be imaged with ease. Intracystic lesions 
were easily picked up, contour of the masses were excel-
lently visualized in spite of associated ﬁ  brocystic mastitis 
and tender breasts could be examined painlessly.
Various limitations and advantages of MG and USG 
are given clearly in Table 6 and 7 respectively.
According to this study, MG had a sensitivity of 81.8 % 
compared to 95.5 % for USG for detecting ﬁ  brocystic 
mastitis, but their combined approach resulted in 100 %. 
Apropos ﬁ  broadenomas, MG showed 75 % sensitivity and 
USG 35 % and the combination 93.7 %. For carcinomas, 
MG had a sensitivity of 77.8 % and USG 55.6 %, but the 
combination had a sensitivity of 98.1 %. Overall, the his-
topathological results when correlated with each modality 
ﬁ  ndings, revealed that MG had a sensitivity of 77.4 % and 
USG 69.8 % when used alone in detecting these lesions of 
the breast compared to a sensitivity of 98.1 % obtained by 
their combined approach. This is shown in Table 8.
This study showed that there was no signiﬁ  cant diﬀ  er-
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Table 5. Mammographic Findings.
S.N0 12345
HPE Fibrocystic Mastitis Fibroadenoma Cyst Infection Malignancy
No: of
Cases
Diagnosed
18 12 2 1 7
Quadrants Upper outer
Upper outer Retro-
areolar
Upper outer any Upper outer
Upper outer, lower 
outer, any
Unilateral (or)
Bilateral Bilateral Both Unilateral Unilateral Unilateral
Density of the lesion Increased
Increased Round, 
Oval & Lobulated
Increased and 
round
Increased density
Asymmetry, 
Increased density
Margin Diﬀ  use Well deﬁ  ned Well deﬁ  ned Well deﬁ  ned Irregular
Ca + + – Coarse – – Micro-calciﬁ  cation
Single
Or Multiple – Both Single Single
Single one 
case showed 
multicentric
Surrounding
Halo – + + –––
Remaining breast pattern – Mixed glandular
Fibro glandular 
Mixed Pattern
Mixed Pattern
Mixed Pattern
 Fatty
Skin thickening – – – Present Present
Fibro–glandular 
architectures Diﬀ  use dense.
Surrounding 
architecture not 
distorted
Surrounding 
architecture not 
distorted
Surrounding 
Architecture not 
distorted
Distorted
Table 6. Various limitations of mammography (MG) and ultrasolongraphy (USG).
Mammography Ultrasonography
Solid and cystic masses cannot be diﬀ  erentiated Operator Dependent
Intracystic lesions cannot be diagnosed Isoechoic masses may be missed especially when small
Young breasts have dense Fibroglandular parenchyma 
and Obscure masses.
Micro-calciﬁ  cation may not be picked up
Fibrocystic mastitis may mask the margins of a lump 
benign lump appears malignant.
Circumscribed carcinoma may be labelled as benign 
masses.
Sector mastitis mimics lumps Lesions within large fatty breasts are diﬃ   cult 
to diagnose
Overlapping structures may limit complete visualization 
of a mass.
Multi-centric carcinoma may be missed.
Abscess and tuberculosis may mimic carcinoma.
Evaluation of Tender breast is diﬃ   cult and often inad-
equate.
Lactating or pregnant patients cannot be adequately 
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Table 7. Given below are the advantages of mammography and ultrasolongraphy.
Mammography Ultrasonography
1. Micro  calciﬁ  cations can be seen well. 1.  Solid and cystic mass can be diﬀ  erentiated.
2.  Multicentric carcinoma can be diagnosed. 2.  Intracystic lesions can be easily picked up.
3.  Characteristics of the mass like margins and loca-
tions are better deﬁ  ned.
3.  Young breasts with dense ﬁ  bro glandular 
parenchyma can be imaged with ease.
4.  Contour of masses excellently visualized in spite 
of associated ﬁ  brocystic mastitis.
5.  All cases of mastitis mimicking a lump can be 
easily distinguished.
6.  Tender breasts can be examined painlessly.
7.  Most abscesses showing-ﬂ  oating debris and can 
easily be diagnosed.
8.  Pregnant patients can be examined safely.
Table 8. Sensitivity of mammography (MG) alone, ultrasonography 
(USG) alone and mammography-ultrasonography combined.
Sensitivity (95% Conﬁ  dence Interval)
No Mammography USG Mammography + USG
Infection 2
Cyst 3
Phylloids 
tumour 1
Fibrocystic 
mastitis 22 (18/22), 81.8% 
(59.7–94.8)
(21/22), 95.5% 
(77.2–99.9)
(22/22), 100% 
(84.6–100)
Fibroadenoma 16 (12/16), 75.0% 
(47.6–92.7)
(5/16), 31.2% 
(11.0–58.6)
(15/16), 93.7% 
(69.8–99.8)
Carcinoma 9 (7/9), 77.8% 
(40.0–97.2)
(5/9), 55.6% 
(21.2–86.3)
(9/9), 100% 
(66.4–100)
Total 53 (41/53), 77.4% 
(64.4–93.6)
(37/53), 69.8% 
(55.6–87.1)
(52/53), 98.1% 
(93.9–100)
Table 9. The diﬀ  erence in p-value between MG and USG, MG alone and MG+USG combined, 
USG alone and MG+USG combined.
MG–USG MG alone – 
(MG + USG combined)
USG alone – 
(MG + USGcombined)
Fibrocystic mastitis 0.159  0.043 0.32
Fibroadenoma 0.0189 0.155 0.0009
Carcinoma 0.328 0.1553 0.0386
Total 0.3768 0.0015 0.0001321 A comparison of mammography and ultrasonography in the evaluation of breast masses
but there was a signiﬁ  cant diﬀ  erence in MG alone and 
MG-USG combination (p = 0.0015) and USG alone and 
USG-MG combination (p = 0.0001). This is shown clearly 
in Table 9.
DISCUSSION
Breast cancer is one of the most prevalent cancers 
in the world among women. Breast masses are common 
and usually benign, but eﬀ  ective evaluation and prompt 
diagnosis can rule out malignancy.
Masses within the breast (whether symptomatic or 
asymptomatic) are frequently diagnosed by mammog-
raphy. It is essential to deﬁ  ne exactly what constitutes 
the lesion mass in order to diﬀ  erentiate benign from ma-
lignant lesions. Mammography, the primary method of 
detection and diagnosis of breast disease has a proven 
sensitivity of 85 % – 95 % 7. However, additional diagnos-
tic procedures often become necessary in view of its low 
speciﬁ  city. Younger women have denser breasts, the use 
of oestrogen replacement therapy increases breast den-
sity and oestrogen replacement therapy use is most com-
mon during and shortly after the begining of menopause 
and declines thereafter. In addition, dense breast paren-
chyma and younger age group are associated with lower 
mammographic sensitivity in some but not all women. 
Presently non-invasive imaging methods like magnetic 
resonance imaging (MRI), thermography and colour 
doppler ultrasound (USG) are being used as adjunctive 
procedures7. Though a deﬁ  nitive diagnosis is possible with 
non-invasive imaging procedures, for most lesions biopsy/
ﬁ  ne needle aspiration cytology are essential for obtain-
ing reliable results7–9. In the majority of cases surgical 
biopsy detects the lesion as benign and has served only to 
provide diagnosis, since surgical removal of these lesions 
are unnecessary unless the clinical signs and symptoms 
warrant for it. Breast cancers are associated with tumour 
angiogenesis. Increase in the number of blood vessels, 
increased vascular permeability, increased tumour blood 
volume, arteriovenous shunt formation, altered capillary 
bed transmit time, increased interstitial pressure due to 
absent lymphatic vessels in tumours result form tumour 
angiogenesis and create characteristic, identiﬁ  able pat-
terns including the distribution pattern of intravenously 
injected contrast medium that can be distinguished from 
those associated with benign lesions. This positive rim 
sign could also be delineated by colour doppler ultrasound 
system. Vessel density in ﬁ  broademonas is more uniform 
throughout the tumour than it is in carcinomas, with no 
statistically signiﬁ  cant diﬀ  erence between periphery and 
centre. Rim enhancing carcinomas were observed to have 
varying degrees of central desmoplasia, associated with 
lower vessel density. Rim enhancement was observed in 
5 of 16 carcinomas, but none of the rim enhancing carci-
nomas exhibited central necrosis7
Patients with palpable breast masses commonly 
present for imaging evaluation. Unfortunately, false-nega-
tive mammographic ﬁ  ndings in the setting of a palpable 
breast mass have been estimated at between 4 % and 
12 %10,11. Therefore, malignancy cannot be excluded when 
mammographic ﬁ  ndings of a palpable mass are negative. 
Treatment of a palpable mass in this setting is based 
on the results of physical examination, with aspiration 
or biopsy performed on clinically suspicious lesions. 
Sonography is used as an adjunct to mammography to 
further evaluate palpable masses, especially in women 
with mammographically dense breasts. Sonography of-
ten detects cysts or solid lesions that are obscured on the 
mammogram by the surrounding ﬁ  broglandular tissue and 
can reduce the number of surgical biopsies required when 
cysts are identiﬁ  ed10, 11. Although the role of sonography 
initially was to establish or exclude the cystic nature of a 
mass, it has expanded with improvements in equipment. 
Sonographic ﬁ  ndings can often conﬁ  rm a cancer that 
is obscured mammographically by dense breast tissue. 
Sonographic technology for breast imaging has dramati-
cally improved in the last decade. With further improve-
ments in sonographic technology and careful prospective 
real-time evaluation of palpable breast lumps, perhaps the 
negative predictive value will one day approach 100 %, 
ideally providing complete conﬁ  dence for follow-up rather 
than recommending biopsy of these lesions.
MG can help physicians determine whether a lesion 
is potentially malignant and also screen for occult disease 
in the surrounding tissue12–14. Radio-opaque ball bearings 
marks the location of the mass and spot compression and 
magniﬁ  cation views can clarify the breast mass and de-
termine its density15, 16. If old ﬁ  lms are available, they are 
compared with the new images. MG is up to 87 percent 
accurate in detecting cancer17–22. Its speciﬁ  city is 88 per-
cent, and its positive predictive value may be as high as 
22 percent22. USG can eﬀ  ectively distinguish solid masses 
from cysts, which account for approximately 25 percent 
of breast lesions18, 19. When strict criteria for cyst diag-
nosis are met, USG has a sensitivity of 89 percent and 
a speciﬁ  city of 78 percent in detecting abnormalities in 
symptomatic women.18 Recurrent or complex cysts may 
signal malignancy; therefore, further evaluation of these 
lesions is required19.
Although USG is not considered a screening test, it 
is more sensitive than MG in detecting lesions in women 
with dense breast tissue18, 20. It is useful in discriminating 
between benign and malignant solid masses,18, 21 and it is 
superior to MG in diagnosing clinically benign palpable 
masses (i.e., up to 97 percent accuracy versus 87 percent 
for MG). 21 It was found from the literatures that MG is a 
well-established diagnostic modality for the breast. It has 
high diagnostic yield, but is not 100 % accurate24, 25. MG 
when combined with USG can yield signiﬁ  cant improve-
ment in accuracy rates.
CONCLUSION
This study conﬁ  rms that MG and USG when com-
bined has higher sensitivity than the sensitivity observed 
for a single modality. The diagnostic accuracy of carcino-322  S. Prasad N, D. Houserková
mas of the breast appear to improve when MG was com-
bined with USG, even in cases which showed no evidence 
of microcalciﬁ  cation or other signs of abnormalities.
The study also implies that, USG may be the only 
modality employed in lactating and pregnant patients as 
it does not involve ionizing radiation and it may also be 
used when the density of the breast tissue precludes MG. 
Similarly, tender breasts with suspected inﬂ  ammation are 
examined with USG, owing to the pain caused by com-
pression.
Thus a combined MG and USG approach to detect 
breast diseases is signiﬁ  cantly more helpful in accurate 
evaluation of breast pathologies than when either modal-
ity is used alone.
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